TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21846985

Group type: EXPERIMENTAL
Intervention: Once daily gentamicin dosing
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Twice daily gentamicin dosing
Number of subjects: 71

Group type: COMPARATOR
Intervention: Both dosing regimens
Number of subjects: 71
Study: 19682220

Group type: EXPERIMENTAL
Intervention: Laser-welded titanium bars
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cast alloy bars (Au-Ag-Pd, Pd-Ag-Au, Au-Ag-Cu-Pd, Ag-Pd-Cu-Au)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tightening sequence (distal ends first)
Number of subjects: 8
Study: 17926624

Group type: EXPERIMENTAL
Intervention: Acupuncture at Hegu (LI 4), Neiguan (PC 6), and Zusanli (ST 36) combined with oral administration of Lidocaine
Number of subjects: 97

Group type: COMPARATOR
Intervention: Lidocaine administration only
Number of subjects: 97
Study: 15523006

Group type: EXPERIMENTAL
Intervention: Serial casting combined with botulinum toxin A (Botox) injection
Number of subjects: 23

Group type: COMPARATOR
Intervention: Serial casting only
Number of subjects: 23
Study: 11720760

Group type: EXPERIMENTAL
Intervention: Platin-based combination chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 every 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single agent therapy with newer cytotoxic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine
Number of subjects: 0
Study: 9246961

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) combined with superovulation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Direct intraperitoneal insemination (DIPI) combined with superovulation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Timed intercourse (TI) combined with superovulation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: All treatments combined (IUI, DIPI, TI) with superovulation
Number of subjects: 70
Study: 7686101

Group type: EXPERIMENTAL
Intervention: Training in rhyming tasks
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Training in blending tasks
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Training in segmenting tasks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no phonological task training)
Number of subjects: 47
Study: 3720306

Group type: EXPERIMENTAL
Intervention: Condoms exposed to UV light for 10 hours
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Condoms exposed to UV light for 5 hours
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Unexposed condoms
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Condoms aged for over 40 months under field conditions
Number of subjects: 130
Study: 29952106

Group type: EXPERIMENTAL
Intervention: Combined therapy with fractional radiofrequency microneedling and 5% topical minoxidil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Monotherapy with 5% topical minoxidil
Number of subjects: 19
Study: 26351332

Group type: EXPERIMENTAL
Intervention: Docetaxel plus trastuzumab plus pertuzumab (THP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel plus trastuzumab (TH)
Number of subjects: 0
Study: 24905061

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Rosiglitazone (RSG) to Metformin (MET)
Number of subjects: 73
Study: 23479456

Group type: EXPERIMENTAL
Intervention: Passive mandibular extension for 10 minutes with partial active masticatory movements
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control conditions (same overall duration without stimulation)
Number of subjects: 18
Study: 19017296

Group type: COMPARATOR
Intervention: Active girls
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Sedentary girls
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Active boys
Number of subjects: 346

Group type: COMPARATOR
Intervention: Sedentary boys
Number of subjects: 346
Study: 18564781

Group type: EXPERIMENTAL
Intervention: 0.1% polyhexanide gel (Prontosan Gel)
Number of subjects: 0
Study: 15717189

Group type: EXPERIMENTAL
Intervention: Needle technique for obtaining autologous cancellous bone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open technique for obtaining autologous cancellous bone
Number of subjects: 50
Study: 12456422

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg plus droperidol 1.25 mg after induction and droperidol 1.25 mg 12 h later (Group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg plus dexamethasone 8 mg after induction and placebo 12 h later (Group 3)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg plus droperidol 1.25 mg after induction and droperidol 1.25 mg 12 h later (Group 2)
Number of subjects: 90
Study: 10605163

Group type: EXPERIMENTAL
Intervention: Carboplatin (CBCDA) 300 mg/m2 day 1, Vindesine (VDS) 3 mg/m2 days 1 and 5, leucovorin (L) 100 mg/m2, 5‐fluorouracil (5‐FU) 370 mg/m2 for 5 days, and 13‐cis retinoic acid (R) 1 mg/kg, administered between chemotherapy courses.
Number of subjects: 28
Study: 7854518

Group type: EXPERIMENTAL
Intervention: Patients who had seizures
Number of subjects: 58

Group type: COMPARATOR
Intervention: Patients who did not have seizures
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Timing of seizures
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Number of seizures
Number of subjects: 58
Study: 1881957

Group type: COMPARATOR
Intervention: Sham ultrasound using placebo cream (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham ultrasound using trolamine salicylate cream (Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ultrasound using placebo cream (Group 3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ultrasound using trolamine salicylate cream (Group 4)
Number of subjects: 40
Study: 6823882

Group type: EXPERIMENTAL
Intervention: Sustagen with 0 mg/kg MSG
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sustagen with 100 mg/kg MSG
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sustagen with 150 mg/kg MSG
Number of subjects: 6

Group type: COMPARATOR
Intervention: MSG in water (150 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sustagen with MSG (all doses)
Number of subjects: 6
Study: 30788599

Group type: EXPERIMENTAL
Intervention: REFS (Rehabilitation following lumbar fusion surgery)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 29546309

Group type: EXPERIMENTAL
Intervention: Resveratrol (200 mg) and Curcumin (100 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 22
Study: 26979085

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 60
Study: 25548744

Group type: EXPERIMENTAL
Intervention: Candesartan and propranolol combination therapy (26 patients)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Propranolol monotherapy (27 patients)
Number of subjects: 53
Study: 21908494

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy plus paroxetine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Prolonged exposure therapy plus placebo
Number of subjects: 37
Study: 19679245

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 13608

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13608
Study: 17456648

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 58
Study: 15093982

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/daily) for 6 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 50
Study: 11135155

Group type: EXPERIMENTAL
Intervention: Trendelenburg head position (‐15 degrees)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Horizontal head position (0 degrees)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Trendelenburg head position (‐15 degrees) and Horizontal head position (0 degrees)
Number of subjects: 128
Study: 10070517

Group type: EXPERIMENTAL
Intervention: Anterior chamber intraocular lenses (AC IOLs) after intracapsular cataract extraction (ICCE)
Number of subjects: 100
Study: 7805078

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study: 2659636

Group type: EXPERIMENTAL
Intervention: Occlusin
Number of subjects: 325

Group type: COMPARATOR
Intervention: Conventional lathe cut amalgam
Number of subjects: 325
Study: 1055242

Group type: EXPERIMENTAL
Intervention: Toothkeeper
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional
Number of subjects: 0
Study: 31178342

Group type: EXPERIMENTAL
Intervention: Primary anastomosis
Number of subjects: 133

Group type: COMPARATOR
Intervention: Hartmann's procedure
Number of subjects: 133
Study: 28340861

Group type: EXPERIMENTAL
Intervention: Aclidinium bromide/formoterol fumarate (AB/FF) 400/12 μg
Number of subjects: 780

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: AB/FF combinations
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Monotherapies
Number of subjects: 780
Study: 25996289

Group type: EXPERIMENTAL
Intervention: NS 440 mg/DPH 50 mg
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: NS 440 mg/DPH 25 mg
Number of subjects: 979

Group type: COMPARATOR
Intervention: NS 440 mg
Number of subjects: 979

Group type: COMPARATOR
Intervention: DPH 50 mg
Number of subjects: 979
Study: 24133038

Group type: EXPERIMENTAL
Intervention: Computerized reading intervention delivered by non-professional tutors
Number of subjects: 137

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 137
Study: 20978739

Group type: EXPERIMENTAL
Intervention: Invitation to screening for diabetes (1990-1992)
Number of subjects: 4936

Group type: EXPERIMENTAL
Intervention: Attended screening at any time point
Number of subjects: 4936

Group type: EXPERIMENTAL
Intervention: Did not attend screening
Number of subjects: 4936

Group type: COMPARATOR
Intervention: Non-invited participants (2000-2003)
Number of subjects: 4936
Study: 18281020

Group type: EXPERIMENTAL
Intervention: Greater vitamin B6 intake
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Greater vitamin B12 intake
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vitamin supplementation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Folate intake
Number of subjects: 32

Group type: COMPARATOR
Intervention: Global brain volume measures
Number of subjects: 32
Study: 16935583

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 0.02% for 30 seconds
Number of subjects: 9

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 9
Study: 12707658

Group type: EXPERIMENTAL
Intervention: Biofeedback rehabilitation training method (30 minutes daily for 10 months)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study: 10751250

Group type: EXPERIMENTAL
Intervention: Whole-brain MR diffusion histogram analysis in MS patients
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Whole-brain MR diffusion histogram analysis in secondary progressive MS patients
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Whole-brain MR diffusion histogram analysis in relapsing-remitting MS patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 25
Study: 8616659

Group type: EXPERIMENTAL
Intervention: Varicose veins
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control veins
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Varicose veins proximally
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control veins proximally
Number of subjects: 14
Study: 1419007

Group type: EXPERIMENTAL
Intervention: Epidural morphine 3 mg and IM saline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epidural saline and IM morphine
Number of subjects: 20
Study: 3907678

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 400 mg daily for 48 h followed by 200 mg daily
Number of subjects: 33

Group type: COMPARATOR
Intervention: Phenylbutazone 800 mg daily for 48 h followed by 400 mg daily
Number of subjects: 33
Study: 31045423

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Stress Management (CBSM)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Health Promotion (HP) attention-matched control
Number of subjects: 192
Study: 28214040

Group type: EXPERIMENTAL
Intervention: 7.5 g/d AX (n=16)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 15 g/d AX (n=17)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (n=14)
Number of subjects: 47
Study: 26962828

Group type: EXPERIMENTAL
Intervention: Multiplex protein biochip comprising 120 biomarkers
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combination of CA19‐9, CA15‐3, and kallikrein‐12
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cathepsin‐B in isolation
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cathepsin‐B with respect to patient's age
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Panels of 4 biomarkers (MMP‐9, cathepsin‐B, C‐reactive protein, chondroitin sulfate)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Panels of 3 biomarkers (CA19‐9, CA15‐3, kallikrein‐12)
Number of subjects: 105
Study: 25315207

Group type: EXPERIMENTAL
Intervention: One scripted telephone call from a diabetes educator or clinical pharmacist
Number of subjects: 2378

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2378
Study: 22353593

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 340

Group type: COMPARATOR
Intervention: 23-valent pneumococcal polysaccharide vaccine (control)
Number of subjects: 340
Study: 21258306

Group type: EXPERIMENTAL
Intervention: Hypertonic seawater solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic seawater solution
Number of subjects: 60
Study: 17628197

Group type: EXPERIMENTAL
Intervention: 90 degrees lateral positioning
Number of subjects: 34
Study: 16277690

Group type: EXPERIMENTAL
Intervention: Pelvic view
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hip AP view
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oblique view
Number of subjects: 50
Study: 12062147

Group type: EXPERIMENTAL
Intervention: Perceptual bias against the onsets [bw] and [dl] in Experiment 1
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Perceptual bias against [dl] in CCV and VCCV contexts in Experiment 2
Number of subjects: 32
Study: 9534100

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 1749

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1749
Study: 7645538

Group type: EXPERIMENTAL
Intervention: Subcutaneous Epoetin alfa (SC) three times per week
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Subcutaneous Epoetin alfa (SC) once per week (n = 20)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Subcutaneous Epoetin alfa (SC) diluted 1:2 with bacteriostatic saline (n = 23)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Subcutaneous Epoetin alfa (SC) three times per week (n = 24)
Number of subjects: 72
Study: 2482270

Group type: EXPERIMENTAL
Intervention: Direct immersion in diethylether and ethanol (1:1 v/v)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Spray fixation (Vale Smear Fix)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Air drying
Number of subjects: 21
Study: 688892

Group type: EXPERIMENTAL
Intervention: Atropine 0.5 mg, hyoscine-N-butylbromide 20 mg, and diazepam 5 mg (Group I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hyoscine-N-butylbromide 20 mg and diazepam 5 mg (Group II)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diazepam 5 mg and glucagon 0.2 mg (Group III)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Only diazepam 5 mg intravenously (Group IV)
Number of subjects: 100
Study: 31807989

Group type: EXPERIMENTAL
Intervention: High-dose regimen
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Individualized regimen
Number of subjects: 492

Group type: COMPARATOR
Intervention: Standard regimen
Number of subjects: 492
Study: 31017657

Group type: EXPERIMENTAL
Intervention: Adalimumab 0.8 mg/kg (40 mg maximum) every other week
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Adalimumab 0.4 mg/kg (20 mg maximum) every other week
Number of subjects: 114

Group type: COMPARATOR
Intervention: Methotrexate 0.1-0.4 mg/kg (25 mg maximum) weekly
Number of subjects: 114
Study: 27428678

Group type: EXPERIMENTAL
Intervention: Downhill Running (DR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Eccentric Resistance Exercise (RE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham Control
Number of subjects: 20
Study: 25769363

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (635 nm), treated twice a week for 3 weeks (total of 6 treatments)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 69
Study: 23549491

Group type: EXPERIMENTAL
Intervention: CoCr‐EES
Number of subjects: 300

Group type: COMPARATOR
Intervention: PtCr‐EES
Number of subjects: 300
Study: 22194126

Group type: EXPERIMENTAL
Intervention: CBTX‐A (Chinese botulinum toxin type A)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Botox (current formulation)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: CBTX‐A
Number of subjects: 273

Group type: COMPARATOR
Intervention: Botox
Number of subjects: 273
Study: 19539814

Group type: EXPERIMENTAL
Intervention: Standard care plus an illness perception intervention (three half-hour patient sessions and one half-hour patient-and-spouse session)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Standard care plus an illness perception intervention
Number of subjects: 103
Study: 16938126

Group type: COMPARATOR
Intervention: PZ levels below the 5.0 percentile (0.52 microg mL‐1)
Number of subjects: 197

Group type: COMPARATOR
Intervention: PZ levels below the 2.5 percentile (0.47 microg mL‐1)
Number of subjects: 197
Study: 15491435

Group type: EXPERIMENTAL
Intervention: Sodium benzoate (75 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: IgE test for food allergy
Number of subjects: 47
Study: 11131270

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker treatment during the study
Number of subjects: 95
Study: 9303862

Group type: EXPERIMENTAL
Intervention: tPA
Number of subjects: 1000

Group type: COMPARATOR
Intervention: tPA (anterior AMI) and streptokinase (non-anterior AMI)
Number of subjects: 1000
Study: 8519378

Group type: EXPERIMENTAL
Intervention: Pre-methacholine FEV1 manoeuvre
Number of subjects: 19

Group type: COMPARATOR
Intervention: No pre-methacholine FEV1 manoeuvre
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Shortened time interval between dose steps (3 min)
Number of subjects: 19
Study: 3302270

Group type: EXPERIMENTAL
Intervention: Laughter-inducing audio tape
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Relaxation-inducing audio tape
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dull-narrative audio tape
Number of subjects: 60

Group type: COMPARATOR
Intervention: No tape
Number of subjects: 60

Group type: COMPARATOR
Intervention: Interesting narrative audio tape
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uninteresting narrative audio tape
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multiplication task
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 60
Study: 30718539

Group type: EXPERIMENTAL
Intervention: Combination of rTMS and ABM training
Number of subjects: 72

Group type: COMPARATOR
Intervention: rTMS alone
Number of subjects: 72

Group type: COMPARATOR
Intervention: ABM treatment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 72
Study: 30324926

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) eyeglasses
Number of subjects: 40

Group type: COMPARATOR
Intervention: No VR eyeglasses (Control)
Number of subjects: 40
Study: 27561000

Group type: EXPERIMENTAL
Intervention: 5% povidone‐iodine applied at the end of surgery
Number of subjects: 65

Group type: COMPARATOR
Intervention: No povidone‐iodine (control group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No povidone‐iodine (group 2)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 5% povidone‐iodine
Number of subjects: 65
Study: 23557912

Group type: EXPERIMENTAL
Intervention: Incentivised Corrected Feedback (ICF)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Consent as Usual (CAU)
Number of subjects: 104
Study: 22178084

Group type: EXPERIMENTAL
Intervention: Armodafinil 150 mg
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Armodafinil 200 mg
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Armodafinil 250 mg
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study: 20453263

Group type: EXPERIMENTAL
Intervention: Johnsons Top‐to‐Toe cleanser (JTT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Sebamed Baby Liquid cleanser (SM)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Lukewarm tap water
Number of subjects: 180
Study: 17364399

Group type: EXPERIMENTAL
Intervention: HIV patient-caregiver relationship quality
Number of subjects: 176

Group type: COMPARATOR
Intervention: Caregiver depression
Number of subjects: 176

Group type: COMPARATOR
Intervention: Caregiver burden
Number of subjects: 176

Group type: COMPARATOR
Intervention: HIV patient depression
Number of subjects: 176

Group type: COMPARATOR
Intervention: Physical functioning
Number of subjects: 176

Group type: COMPARATOR
Intervention: HIV medication adherence
Number of subjects: 176
Study: 16289803

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for chronic pain
Number of subjects: 78
Study: 12109952

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (5 mg bolus injections at 5 min intervals)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 10
Study: 10546840

Group type: EXPERIMENTAL
Intervention: Intramuscular artemether (3.2‐mg/kg loading dose followed by 1.6 mg/kg daily)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Intravenous quinine (20‐mg/kg loading dose followed by 10 mg/kg every 8 h)
Number of subjects: 103